(Q41915008)

English

Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: A study of one hundred thirty‐three cases compared with a control group

scientific article published on November 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: A study of one hundred thirty‐three cases compared with a control group (English)

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

hydroxychloroquine

1 reference

based on heuristic

inferred from title

connective tissue

1 reference

based on heuristic

inferred from title

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

Nathalie Costedoat-Chalumeau

1

object named as

Nathalie Costedoat-Chalumeau

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

2

object named as

Zahir Amoura

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Jean-Charles Piette

10

object named as

Jean-Charles Piette

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Bertrand Wechsler

6

object named as

Bertrand Wechsler

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

3

object named as

Pierre Duhaut

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Danièle Vauthier

7

object named as

Danièle Vauthier

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Isabelle Denjoy

8

object named as

Isabelle Denjoy

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Jean-Marc Lupoglazoff

9

object named as

Jean-Marc Lupoglazoff

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

author name string

Du Le Thi Huong

4

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Djamel Sebbough

5

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14613284

31 March 2024

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.11304

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.11304

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Arthritis and Rheumatism

48

11

3207–11

publication date

November 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14613284

31 March 2024

48

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

3207-3211

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

1

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

Bioavailability of hydroxychloroquine tablets in healthy volunteers

2

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

Antimalarial drugs and pregnancy

4

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

Hydroxychloroquine in pregnant patients with systemic lupus erythematosus

5

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases

6

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

Antimalarial agents in pregnancy

7

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases

8

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study.

9

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

Evidence of transplacental passage of hydroxychloroquine in humans

10

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

The 1982 revised criteria for the classification of systemic lupus erythematosus

11

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community

12

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

13

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

The safety of antimalarial drugs in pregnancy

15

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility

16

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

Ototoxicity of Chloroquine

17

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 38-1988. A 58-year-old woman with fever, sweats, congestive heart failure, and lymphadenopathy after treatment for a diagnosis of systemic lupus erythemat

18

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

Survey of antimalarial use in lupus pregnancy and lactation

19

1 reference

10.1002/ART.11304

https://api.crossref.org/works/10.1002/ART.11304

31 March 2024

Identifiers

10.1002/ART.11304

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41915008&oldid=2115900373"